Makby

Makby operates in the 3D bioprinting sector, addressing the limitations of current software used for generating bioprinted models. The company provides a comprehensive solution that integrates various printing technologies and biomaterials, facilitating a seamless and efficient bioprinting workflow. Makby serves clients involved in bioprinting, offering a user-friendly interface that simplifies the design and combination of 2D and 3D constructs. The business model revolves around providing customized solutions through feasibility studies and tailored protocols, ensuring that clients can achieve precise control over their printing processes. Revenue is generated by offering these specialized services and solutions to organizations engaged in bioprinting research and development. The market for Makby includes research institutions, biotech companies, and other entities focused on advancing bioprinting technologies. The company is also involved in initiatives like FORCE REPAIR, funded by the European Horizon Europe Research and Innovation programme, which underscores its commitment to advancing bioprinting capabilities. Keywords: 3D bioprinting, biomaterials, workflow, software, feasibility studies, printing technologies, constructs, protocols, research, algorithms.